The Influence of EGFR Inactivation on the Radiation Response in High Grade Glioma.

about

The Influence of EGFR Inactivation on the Radiation Response in High Grade Glioma.

Item

http://www.wikidata.org/entity/Q49703767

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh-hant

name

The Influence of EGFR Inactivation on the Radiation Response in High Grade Glioma.

@en

The Influence of EGFR Inactivation on the Radiation Response in High Grade Glioma.

@nl

type

Item

label

The Influence of EGFR Inactivation on the Radiation Response in High Grade Glioma.

@en

The Influence of EGFR Inactivation on the Radiation Response in High Grade Glioma.

@nl

prefLabel

The Influence of EGFR Inactivation on the Radiation Response in High Grade Glioma.

@en

The Influence of EGFR Inactivation on the Radiation Response in High Grade Glioma.

@nl

P1476

The Influence of EGFR Inactivation on the Radiation Response in High Grade Glioma.

@en

P2093

Anica Dricu

http://www.w3.org/2001/XMLSchema#string

Catalin Folcuţi

http://www.w3.org/2001/XMLSchema#string

Cristian Tuţă

http://www.w3.org/2001/XMLSchema#string

Juan Castro

http://www.w3.org/2001/XMLSchema#string

Laura Lucan

http://www.w3.org/2001/XMLSchema#string

Ligia Gabriela Tataranu

http://www.w3.org/2001/XMLSchema#string

Oana Alexandru

http://www.w3.org/2001/XMLSchema#string

Stefan-Alexandru Artene

http://www.w3.org/2001/XMLSchema#string

Stefana Oana Purcaru

http://www.w3.org/2001/XMLSchema#string

P2860

Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1

The in vitro effect of gefitinib ('Iressa') alone and in combination with cytotoxic chemotherapy on human solid tumours

Targeted molecular therapies against epidermal growth factor receptor: past experiences and challenges

Prognostic value of epidermal growth factor receptor in patients with glioblastoma multiforme.

Glioma stem cells promote radioresistance by preferential activation of the DNA damage response

The somatic genomic landscape of glioblastoma

Quantitative analysis of dose-effect relationships: the combined effects of multiple drugs or enzyme inhibitors

Treatment of primary glioblastoma multiforme with cetuximab, radiotherapy and temozolomide (GERT)--phase I/II trial: study protocol.

Randomized phase II trial of erlotinib versus temozolomide or carmustine in recurrent glioblastoma: EORTC brain tumor group study 26034.

Clinical significance of EGFR amplification and the aberrant EGFRvIII transcript in conventionally treated astrocytic gliomas.

P31

scholarly article

P356

10.3390/IJMS19010229

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2018-01-12T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29329222

http://www.w3.org/2001/XMLSchema#string

P932

5796178

http://www.w3.org/2001/XMLSchema#string